While experimental evidence supports the neuroprotective potential of GLP-1 activation, further research is necessary to expand this work into the clinical setting and uncover the full therapeutic potential of GLP-1 RAs in stroke management and prevention. The gene discussed is GCG; the disease is Stroke.